Anti-CD2 x Anti-TCR (Vβ8) Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-CD2 and anti-TCR (Vβ8) parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can activate T cells. It is designed for the research of Tumors therapy.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRY